[Antishock effect of anisodamine in comparison with that of dopamine and aramine].
D000316:Adrenergic alpha-Agonists / Q000627:therapeutic use*; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D004298:Dopamine / Q000627:therapeutic use*; D006339:Heart Rate / Q000187:drug effects; D008297:Male; D008680:Metaraminol / Q000627:therapeutic use*; D010276:Parasympatholytics / Q000627:therapeutic use*; D011817:Rabbits; D012769:Shock / Q000188:drug therapy* / Q000503:physiopathology; D012991:Solanaceous Alkaloids / Q000627:therapeutic use*
D000316:Adrenergic alpha-Agonists; D010276:Parasympatholytics; D012991:Solanaceous Alkaloids; C003922:anisodamine; D008680:Metaraminol; D004298:Dopamine